Investigating how SK3 channels in blood vessel cells affect blood pressure regulation
SK3 channel trafficking in endothelial cells
This study is looking at how certain channels in the cells lining your blood vessels work and how they might be affected when someone has high blood pressure, with the hope of finding new ways to help improve heart and blood vessel health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10832461 on NIH RePORTER |
What this research studies
This research focuses on endothelial cells, which line blood vessels and play a crucial role in regulating blood pressure and vascular function. The study aims to understand how small-conductance calcium-activated potassium (SK3) channels are trafficked to the cell surface and how this process is affected in conditions like hypertension. By using various experimental approaches, the researchers will explore the mechanisms that control the abundance of these channels and their impact on arterial contractility and vasodilation. This could lead to insights into the dysfunction of these channels in cardiovascular diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with hypertension or other cardiovascular diseases that may involve endothelial dysfunction.
Not a fit: Patients without cardiovascular issues or those who do not have endothelial cell dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing hypertension and other cardiovascular disorders.
How similar studies have performed: Previous research has shown promising results in understanding the role of ion channels in vascular function, suggesting that this approach could yield valuable insights.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Jaggar, Jonathan H — University of Tennessee Health Sci Ctr
- Study coordinator: Jaggar, Jonathan H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.